Jacobs & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.4M Buy
10,294
+244
+2% +$128K 0.54% 67
2025
Q1
$6.37M Buy
10,050
+859
+9% +$545K 0.68% 63
2024
Q4
$6.55M Buy
9,191
+64
+0.7% +$45.6K 0.67% 59
2024
Q3
$9.59M Sell
9,127
-290
-3% -$305K 0.96% 44
2024
Q2
$9.9M Sell
9,417
-59
-0.6% -$62K 1.04% 41
2024
Q1
$9.12M Sell
9,476
-45
-0.5% -$43.3K 0.97% 47
2023
Q4
$8.36M Sell
9,521
-161
-2% -$141K 0.95% 46
2023
Q3
$7.97M Sell
9,682
-270
-3% -$222K 0.99% 45
2023
Q2
$7.15M Sell
9,952
-295
-3% -$212K 0.85% 53
2023
Q1
$8.42M Sell
10,247
-1,019
-9% -$837K 1.04% 44
2022
Q4
$8.13M Sell
11,266
-416
-4% -$300K 1.06% 42
2022
Q3
$8.05M Buy
11,682
+108
+0.9% +$74.4K 1.16% 40
2022
Q2
$6.84M Sell
11,574
-697
-6% -$412K 0.92% 52
2022
Q1
$8.57M Sell
12,271
-419
-3% -$293K 0.95% 52
2021
Q4
$8.01M Buy
12,690
+341
+3% +$215K 0.83% 55
2021
Q3
$7.47M Buy
12,349
+169
+1% +$102K 0.86% 54
2021
Q2
$6.8M Buy
12,180
+145
+1% +$81K 0.79% 57
2021
Q1
$5.69M Buy
12,035
+1,177
+11% +$557K 0.7% 61
2020
Q4
$5.25M Buy
10,858
+1,750
+19% +$845K 0.68% 60
2020
Q3
$5.1M Buy
9,108
+4,304
+90% +$2.41M 0.74% 58
2020
Q2
$3M Sell
4,804
-1,160
-19% -$723K 0.49% 69
2020
Q1
$2.91M Buy
+5,964
New +$2.91M 0.56% 68
2018
Q1
Sell
-31,557
Closed -$996K 123
2017
Q4
$996K Sell
31,557
-3,900
-11% -$123K 0.18% 91
2017
Q3
$1.13M Sell
35,457
-2,440
-6% -$78K 0.21% 89
2017
Q2
$1.21M Sell
37,897
-275
-0.7% -$8.74K 0.24% 88
2017
Q1
$1.22M Sell
38,172
-14,032
-27% -$449K 0.25% 88
2016
Q4
$1.49M Buy
52,204
+51,345
+5,977% +$1.46M 0.32% 82
2016
Q3
$345K Buy
+859
New +$345K 0.08% 108